All In Biotech

Drug Trial Radar · NCT04357795

Effect of Cequa™ in Subjects With Dry Eye Disease

Effect of Cequa™ in Subjects With Dry Eye Disease That Is Currently Inadequately Controlled While on Cyclosporine 0.05% Ophthalmic Emulsion

Last checked: Nov 20, 2026Latest source record: Feb 6, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

135

Actual

Start

Jun 29, 2020

Primary completion

Jun 24, 2022

Study completion Jun 24, 2022

Sponsor

Sponsor type
Industry
First posted
Apr 22, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase 4, multicenter, single arm, 12 week study in subjects with dry eye disease, which is inadequately controlled by cyclosporine 0.05% ophthalmic emulsion.

Conditions

  • Dry Eye Disease

Interventions

  • CequaTM (Cyclosporine 0.09%) ophthalmic solutionDrug

    One drop CequaTM (Cyclosporine 0.09%) ophthalmic solution in each eye twice daily, approximately 12 hours apart.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean Change in Baseline in Total Corneal Fluoroscein Staining ScoreTime frame: Week12
  2. Change From Baseline in Modified Dry Eye Scoring.Time frame: Week12

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Eye Associates of Fort Myers, 4225 Evans Ave.

    Fort Myers, Florida

  • Bowden Eye and Associates, 7205 Bonneval Road

    Jacksonville, Florida

  • Eye Center of N Florida, 2500 Martin Luther King Jr Blvd

    Panama City, Florida

  • Kannarr Eye Care, 2521 N Broadway

    Pittsburg, Kansas

  • Texas Eye and Laser Center, 1872 Norwood Dr. #200

    Hurst, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.